by Abby Zimet
A day after Glaxo agreed to pay the largest drug fraud settlement ever for illegally marketing anti-depressants - and as further if redundant proof that Big Pharma will do anything to make a buck - comes news that Purdue Pharma is trying to get six more months of patent protection for its wildly profitable, highly addictive painkiller OxyContin - second cousin to morphine and heroin - by trying it out on kids as young as six. The company, which in a landmark case already paid $635 million in fines after being found guilty of misleading doctors and the public about OxyContin’s risk of addiction, says it is doing the pediatric trials so doctors "can make better decisions about the care of their patients.”
They also have a bridge to sell you. Shameless.
